| Literature DB >> 35206206 |
Wei Wang1, Sifen Lu2, Haoxiang Tang3, Biao Wang1, Caiping Sun1, Pai Zheng4, Yi Bai5, Zuhong Lu6, Yulin Kang1.
Abstract
The phenomenon of drug epidemics has been a global issue in the past decades, causing enormous damages to the physical and mental health of drug users and social well-being. Despite great efforts to curb drug epidemics at the governmental or social level, the total number of drug users has still been on the rise in recent years, along with illicit production and trafficking around the world. Inspired by dynamical epidemic models of infectious disease, a flourishment of promising results has been observed in the exploration of drug epidemic models. In this review, we aim to provide a scoping review of all existing drug epidemic modeling studies, and it has been shown that most studies focused on analyses of theoretical behaviors of the model systems, lacking emphasis on practical applications in real settings. We found that the drug epidemic models were characterized by a longer time scale, no incubation period, no significant prevention vaccines interfered, and population specificity. This review could assist policymakers and public health workers in gaining deeper insights into modeling tools, and help modelers improve their works, thus narrowing gaps between mathematical epidemiology and public health studies.Entities:
Keywords: drug epidemic model; mathematical epidemiology; nonlinear dynamic systems
Mesh:
Year: 2022 PMID: 35206206 PMCID: PMC8872096 DOI: 10.3390/ijerph19042017
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1PRISMA diagram of study selection processes.
Model characteristics and settings of included studies.
| Study | Number of Compartment a | Equation Type b | Incidence Function | Intervention | Drug Type | Scenario |
|---|---|---|---|---|---|---|
| Hoppensteadt 1981 | 2 | PDE | bilinear | parameter | - | - |
| Knolle 1997 | 2 | ODE | linear | - | multiple | Switzerland, 1979–1995 |
| Almeder 2004 | 2 | PDE | complex | parameter | - | - |
| Caulkins 2007 | 5 | DE | linear | parameter | illicit drug | Australia, 1960–2010 |
| Caulkins 2009 | 2 | ODE | complex | - | - | Australian IDU and US cocaine |
| Caulkins 2010 | 2 | ODE | complex | - | - | Australian IDU and US cocaine |
| White 2007 | 3 | ODE | standard | both | heroin | - |
| Mulone 2009 | 3 | ODE | standard | compartment | heroin | - |
| Nyabadza 2010 | 5 | ODE | complex | both | methamphetamine | South Africa, 1996–2008 |
| Samanta 2011 | 3 | DDE | bilinear | both | heroin | - |
| Wang 2011 | 3 | ODE | standard | compartment | heroin | - |
| Liu 2011 | 3 | DDE | bilinear | both | heroin | - |
| Kalula 2012 | 6 | ODE | complex | both | methamphetamine | South Africa, 1996–2009 |
| Huang 2013 | 3 | DDE | bilinear | compartment | heroin | - |
| Nyabadza 2013 | 6 | ODE | complex | both | methamphetamine | South Africa, 1997–2010 |
| Muroya 2014 | 3 | ODE | bilinear | compartment | light drug | - |
| Abdurahman 2014 | 3 | DE | bilinear | both | heroin | - |
| Fang 2014 | 3 | DDE | bilinear | both | heroin | - |
| Fang 2015 a | 3 | PDE | bilinear | both | heroin | - |
| Fang 2015 b | 3 | PDE | bilinear | both | heroin | - |
| Mushanyu 2015 | 4 | ODE | complex | compartment | methamphetamine | South Africa, 1999–2013 |
| Liu 2016 | 3n | DDE | complex | compartment | heroin | - |
| Yang 2016 | 3n | ODE | complex | both | heroin | - |
| Yang 2016 | 3 | PDE | complex | both | heroin | - |
| Mushanyu 2016 | 5 | ODE | complex | both | - | South Africa |
| Liu 2016 | 3n | DDE | complex | both | heroin | - |
| Djilali 2017 | 3 | PDE | complex | both | heroin | - |
| Wangari 2017 | 4 | ODE | bilinear | both | heroin | - |
| Mushanyu 2017 | 4 | ODE | complex | both | methamphetamine | South Africa, 2000–2013 |
| Li 2018 a | 3 | SDE | bilinear | compartment | heroin | - |
| Ma 2018 | 4 | ODE | complex | both | synthetic drug | - |
| Li 2018b | 6 | ODE | bilinear | both | - | - |
| Naowarat 2018 | 5 | ODE | complex | compartment | methamphetamine | - |
| Wang 2019 | 3n | PDE | bilinear | both | heroin | - |
| Liu 2019 | 3 | SDE | bilinear | both | heroin | - |
| Liu 2019 | 3 | SDE | standard | both | heroin | - |
| Duan 2019 | 4 | PDE | bilinear | compartment | heroin | - |
| Wei 2019 | 3 | SDE | standard | compartment | heroin | - |
| Su 2019 | 3 | ODE | linear | - | multiple | China, 2000–2030 |
| Memarbashi 2019 | 5 | ODE | standard | compartment | heroin | - |
| Abdurahman 2019 | 4 | DDE | complex | compartment | heroin | - |
| Zhang 2019 | 4 | DDE | bilinear | compartment | synthetic drug | - |
| Liu 2019 | 3 | PDE | bilinear | both | heroin | - |
| Liu 2019 | 4 | ODE | bilinear | both | synthetic drug | - |
| Rafiq 2019 | 3 | SDE | bilinear | compartment | heroin | - |
| Saha 2019 | 4 | ODE | complex | both | synthetic drug | South Africa |
| Duan 2020 | 5 | ODE | standard | parameter | heroin and HIV | USA, 2005–2017 |
| Duan 2020 | 3 | PDE | bilinear | compartment | heroin | - |
a Number of compartments include expressions containing n, which denotes that the model was stratified into n parallel layers. b Abbreviations: ODE (ordinary differential equations), PDE (partial differential equations), DE (difference equations), DDE (delayed differential equations), SDE (stochastic differential equations). For simplicity, a coupled system of PDE and ODE is referred to as PDE, and the same rule applies to other equation types.
Figure 2Mathematical expressions of all the drug epidemic models.